U.S. Markets closed
  • S&P Futures

    4,240.00
    +8.50 (+0.20%)
     
  • Dow Futures

    33,842.00
    +83.00 (+0.25%)
     
  • Nasdaq Futures

    14,297.25
    +34.25 (+0.24%)
     
  • Russell 2000 Futures

    2,307.90
    +7.60 (+0.33%)
     
  • Crude Oil

    73.15
    +0.07 (+0.10%)
     
  • Gold

    1,778.60
    -4.80 (-0.27%)
     
  • Silver

    25.96
    -0.15 (-0.58%)
     
  • EUR/USD

    1.1930
    -0.0003 (-0.0239%)
     
  • 10-Yr Bond

    1.4870
    +0.0150 (+1.02%)
     
  • Vix

    16.32
    -0.34 (-2.04%)
     
  • GBP/USD

    1.3957
    -0.0007 (-0.0475%)
     
  • USD/JPY

    111.0400
    +0.0780 (+0.0703%)
     
  • BTC-USD

    33,254.13
    -854.80 (-2.51%)
     
  • CMC Crypto 200

    798.97
    -11.22 (-1.38%)
     
  • FTSE 100

    7,074.06
    -15.95 (-0.22%)
     
  • Nikkei 225

    28,911.52
    +36.63 (+0.13%)
     

First of three S.Korea expert panels recommends approval of Moderna COVID-19 vaccine

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

SEOUL, May 10 (Reuters) - The first of three expert panels in South Korea gave its recommendation on Monday for the government to grant approval of the Moderna COVID-19 vaccine based on safety and efficacy of the shots in the U.S. phase 3 trial.

The national pharmaceutical panel is scheduled to make its recommendation on Thursday, but the government will wait for a third panel, which has not said when it will reach its conclusion, before deciding whether to grant approval.

(Reporting by Sangmi Cha; Editing by Kim Coghill)